Magnetar Financial’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-267,508
| Closed | -$95.5K | – | 996 |
|
|
2024
Q4 | $95.5K | Buy |
+267,508
| New | +$95.5K | ﹤0.01% | 575 |
|
|
2023
Q3 | – | Sell |
-620,574
| Closed | -$6.41M | – | 607 |
|
|
2023
Q2 | $6.41M | Sell |
620,574
-362,133
| -37% | -$3.74M | 0.14% | 111 |
|
|
2023
Q1 | $9.95M | Sell |
982,707
-17,293
| -2% | -$175K | 0.19% | 105 |
|
|
2022
Q4 | $9.95M | Hold |
1,000,000
| – | – | 0.17% | 146 |
|
|
2022
Q3 | $9.75M | Buy |
1,000,000
+919,400
| +1,141% | +$8.96M | 0.14% | 185 |
|
|
2022
Q2 | $783 | Buy |
80,600
+62,900
| +355% | +$611 | 0.01% | 1040 |
|
|
2022
Q1 | $172K | Buy |
+17,700
| New | +$172K | ﹤0.01% | 1066 |
|